Priority programme
Ovarian Cancer
Molecular profiling, BRCA testing pathways, and primary cytoreduction outcomes in Saudi women.
- Active studies
- 6
- Centres
- 14
Research & Innovations
A national dataset, a Saudi evidence base.
Our registry, trials network and grants programme give the Saudi gynecologic oncology community the tools to answer local questions with local data.
National Registry — live dashboard
The evidence base for Saudi gynecologic oncology.
Updated November 2026
Multi-cohort
0
Cases enrolled
Across 11 regions
0
Contributing centres
Genomic profiling
0%
Cases with molecular data
Longitudinal
0 yrs
Median follow-up
Research focus areas
Six programmes shaping practice in the Kingdom.
Each focus area is led by a senior investigator group and reviewed annually against WHO and national elimination targets.
National elimination goal
Cervical Cancer
HPV vaccination coverage, screening access, and real-world outcomes across the Kingdom's regions.
- Active studies
- 5
- Cohort
- 42k
Regional collaboration
Endometrial Cancer
Molecular subtypes, sentinel lymph node biopsy, and MENA-wide risk stratification models.
- Active studies
- 4
- MENA partners
- 8
Translational science
Molecular Oncology
Genomic sequencing, tumour biobanking, and biomarker discovery aligned to Saudi genomic initiatives.
- Samples
- 5,900+
- Assays
- 12
GCP-certified network
Clinical Trials
Investigator-initiated and industry-sponsored trials coordinated across accredited Saudi centres.
- Open trials
- 17
- Sites
- 22
Longitudinal dataset
National Registry
The National Gynecologic Cancer Registry — one of MENA's largest curated datasets for practice and policy.
- Cases
- 10,240
- Follow-up
- 8 yrs
Active projects
Answering the questions that matter here.
A curated portfolio of investigator-initiated and multi-centre studies conducted across the Kingdom and MENA.
Recruiting Active Follow-up
SAGE-1Recruiting
2024 — 2027Molecular profiling of high-grade serous ovarian cancer in Saudi women.
PI: Prof. Amal Al-Harbi, MD, PhD
Institutions: KFSH&RC · KAUH · KSU · PSMMC
Funding: SAR 1.8M · KACST
CERV-KSAFollow-up
2021 — 2026Real-world outcomes of HPV vaccination in the Kingdom, five-year follow-up.
PI: Dr. Reem Al-Otaibi, MBBS, MSc
Institutions: Ministry of Health · KFMC · Jeddah Regional Lab
Funding: SAR 950K · MoH
ENDO-MENAActive
2025 — 2028Regional collaboration on endometrial cancer molecular subtypes across MENA.
PI: Prof. Khalid Al-Ghamdi, MD
Institutions: SSGO · ESGO · Cairo Uni. · AUH
Funding: SAR 2.4M · Consortium
Access-StudyData analysis
2023 — 2026Time-to-treatment across public and private Saudi hospitals: an equity analysis.
PI: Dr. Norah Al-Dossari, MPH
Institutions: SSGO · Saudi Health Council · KFSH&RC
Funding: SAR 640K · SSGO Grants
Academic library
Selected peer-reviewed publications.
Filter by year, topic, journal or author. Full abstracts, DOIs and open-access PDFs where permitted by the publisher.
0/6
Publications shown
- Int. J. Gynecologic CancerIF 4.8 · 2025
Outcomes of primary cytoreduction for advanced ovarian cancer in Saudi Arabia.
Al-Harbi A, Al-Sayed M, Al-Otaibi R, et al.
OvarianDOI · 10.1136/ijgc-2025-004821 - VaccineIF 5.2 · 2024
HPV prevalence and vaccination coverage among Saudi adolescents: a national survey.
Al-Otaibi R, Al-Ghamdi K, Al-Dossari N, et al.
CervicalDOI · 10.1016/j.vaccine.2024.06.031 - Gynecologic OncologyIF 4.9 · 2024
Sentinel lymph node biopsy in early endometrial cancer: a Saudi prospective cohort.
Al-Ghamdi K, Al-Harbi A, et al.
EndometrialDOI · 10.1016/j.ygyno.2024.03.014 - JCO Global OncologyIF 3.6 · 2025
The National Gynecologic Cancer Registry: design, governance and 10,000-case milestone.
SSGO Registry Working Group
RegistryDOI · 10.1200/GO.25.00112 - The Lancet Regional Health — Eastern MediterraneanIF 6.1 · 2023
Equity in oncology access: a policy analysis of referral pathways in the Kingdom.
Al-Dossari N, Al-Harbi A, et al.
PolicyDOI · 10.1016/j.lanepe.2023.100742 - JAMA OncologyIF 8.4 · 2023
BRCA1/2 mutation spectrum in Saudi ovarian cancer patients: implications for testing.
Al-Sayed M, Al-Otaibi R, et al.
OvarianDOI · 10.1001/jamaoncol.2023.02189
Research impact
A measurable contribution to global oncology.
The Society's research portfolio delivers evidence used by clinicians, policy-makers and international guideline committees.
0
Peer-reviewed publications
2018 — 2026
0
Citations
Scopus & Web of Science
0
International collaborations
18 countries
0+
Research grants awarded
SAR 41M total
0
Participating institutions
11 Saudi regions
0
Global society partnerships
ESGO · ASCO · IGCS
Partner institutions
Universities, hospitals and international societies.
Research is delivered in collaboration with the Kingdom's leading academic medical centres and global oncology societies.
King Faisal Specialist Hospital & Research Centre
King Saud University
King Abdulaziz University
Prince Sultan Military Medical City
King Fahad Medical City
Ministry of Health, Saudi Arabia
KACST
Saudi Health Council
ESGO — European Society of Gynaecological Oncology
ASCO — American Society of Clinical Oncology
Call for proposals
2026 Research Grants — up to SAR 250,000 per project.
Investigator-initiated proposals in ovarian, cervical, endometrial and molecular oncology. Reviewed by an independent international committee.